CUE - Cue Biopharma Inc. (CUE) CEO Dan Passeri on Q2 2021 Results - Earnings Call Transcript
Cue Biopharma, Inc. (CUE) Q2 2021 Results Conference Call August 17, 2021 04:30 PM ET Company Participants Dr. George Zavoico - VP, IR & Corporate Development Dan Passeri - Chief Executive Officer Dr. Anish Suri - President & Chief Scientific Officer Dr. Ken Pienta - Acting Chief Medical Officer Dr. Matteo Levisetti - SVP, Clinical Development Kerri-Ann Millar - Chief Financial Officer Conference Call Participants Mark Breidenbach - Oppenheimer Stephen Wiley - Stifel Tom Shrader - BTIG Brian Skorney - Baird Zhiqiang Shu - Berenberg Presentation Operator Greetings, and welcome to the Cue Biopharma Second Quarter 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Dr. George Zavoico. Thank you, George. You may begin. Dr. George Zavoico Thanks, Paul,
For further details see:
Cue Biopharma, Inc. (CUE) CEO Dan Passeri on Q2 2021 Results - Earnings Call Transcript